Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP(UK)
Diabetologist
M.B.B.S., MPhill (Bio-Chemistry), PhD
General Physician
M.B.B.S, MCPS (Family Medicine)
Internal Medicine Specialist
MD, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, MRCP (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures